Skip to main content

Follow-Up

  • Reference work entry
  • First Online:
Handbook of Neurourology
  • 425 Accesses

Abstract

Due to their complex etiology and pathogenesis, symptoms of neurogenic bladder differ significantly in their pattern, severity, degree to which they affect quality of life, and their potential to lead to complications. Guidelines for diagnostic and therapeutic algorithms exist and are periodically being updated (Ginsberg et al. J Urol., 2021). The need for individualized, “risk-adapted” management has been stressed in recent years. The main goal of neurogenic bladder therapy is preservation of the upper urinary tract and achievement of complete or at least socially acceptable urinary continence. This is very important as incontinence represents a symptom with the most pronounced effect on quality of life.

Neurogenic bladder dysfunction is a dynamic condition, which changes over time. It is, therefore, essential that every patient be regularly evaluated by a urologist. Regular follow-up visits allow for timely adjustments to therapy that coincides with changes throughout the course of disease and early detection of risk factors, which could lead to complications. Diagnostic methods used in the follow-up period and the frequency of follow-up visits must be individualized. Urological literature published to date contains mostly data assessing the treatment and follow-up of patients following spinal cord injury (SCI). Data from randomized clinical studies, which formulate daily clinical practice recommendations for other types of neurogenic bladder, are sparse.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 999.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 999.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. D.A. Ginsberg, T.B. Boone, A.P. Cameron, et al., The AUA/SUFU guideline on adult neurogenic lower urinary tract dysfunction: Treatment and follow-up. J. Urol. (2021). https://doi.org/10.1097/JU0000000000002239

  2. M.E. García Leoni, A. Esclarín De Ruz, Management of urinary tract infection in patients with spinal cord injuries. Clin. Microbiol. Infect. 9(8), 780–785 (2003)

    Article  PubMed  Google Scholar 

  3. J.M. Hoffman, R. Wadhwani, E. Kelly, B. Dixit, D.D. Cardenas, Nitrite and leukocyte dipstick testing for urinary tract infection in individuals with spinal cord injury. J. Spinal Cord Med. 27(2), 128–132 (2004)

    Article  PubMed  Google Scholar 

  4. T.A. Linsenmeyer, A. Oakley, Accuracy of individuals with spinal cord injury at predicting urinary tract infections based on their symptoms. J. Spinal Cord Med. 26(4), 352–357 (2003)

    Article  PubMed  Google Scholar 

  5. J. Penders, A.A. Huylenbroeck, K. Everaert, M. Van Laere, G.L. Verschraegen, Urinary infections in patients with spinal cord injury. Spinal Cord 41(10), 549–552 (2003)

    Article  CAS  PubMed  Google Scholar 

  6. E.J. Erlandsen, E. Randers, J.H. Kristensen, Reference intervals for serum cystatin C and serum creatinine in adults. Clin. Chem. Lab. Med. 36, 393–397 (1998)

    Article  CAS  PubMed  Google Scholar 

  7. S.A. Thomassen, I.L. Johannesen, E.J. Erlandsen, J. Abrahamsen, E. Randers, Serum cystatin C as a marker of the renal function in patients with spinal cord injury. Spinal Cord 40(10), 524–528 (2002)

    Article  CAS  PubMed  Google Scholar 

  8. A.P. Cameron, G.M. Rodriguez, K.G. Schomer, Systematic review of urological followup after spinal cord injury. J. Urol. 187(2), 391–397 (2012)

    Article  PubMed  Google Scholar 

  9. M.A. Averbeck, H. Madersbacher, Follow-up of the neuro-urological patient: A systematic review. BJU Int. 115(Suppl 6), 39–46 (2015). https://doi.org/10.1111/bju.13084

    Article  PubMed  Google Scholar 

  10. Z. Zhang, L. Liao, Risk factors predicting upper urinary tract deterioration in patients with spinal cord injury: A prospective study. Spinal Cord 52(6), 468–471 (2014)

    Article  CAS  PubMed  Google Scholar 

  11. B. Çetinel, B. Önal, G. Can, Z. Talat, B. Erhan, B. Gündüz, Risk factors predicting upper urinary tract deterioration in patients with spinal cord injury: A retrospective study. Neurourol. Urodyn. (2016). https://doi.org/10.1002/nau.22984. [Epub ahead of print]

  12. M. Elmelund, N. Klarskov, P. Bagi, P.S. Oturai, F. Biering-Sørensen, Renal deterioration after spinal cord injury is associated with length of detrusor contractions during cystometry-a study with a median of 41 years follow-up. Neurourol. Urodyn. (2016). https://doi.org/10.1002/nau.23163. [Epub ahead of print]

  13. U. Sammer, M. Walter, S.C. Knüpfer, U. Mehnert, B. Bode-Lesniewska, T.M. Kessler, Do we need surveillance urethro-cystoscopy in patients with neurogenic lower urinary tract dysfunction? PLoS One 10(10), e0140970 (2015). https://doi.org/10.1371/journal.pone.0140970

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. B. Welk, The argument against screening for bladder cancer in neuro-urological patients. World J. Urol. 40(8), 1915–1919 (2021)

    Article  PubMed  Google Scholar 

  15. W.S. El Masri, S. Patil, K.V. Prasanna, J.R. Chowdhury, To cystoscope or not to cystoscope patients with traumatic spinal cord injuries managed with indwelling urethral or suprapubic catheters? That is the question! Spinal Cord 52(1), 49–53 (2014)

    Article  Google Scholar 

  16. T. Müller, K. Arbeiter, C. Aufricht, Renal function in meningomyelocele: Risk factors, chronic renal failure, renal replacement therapy and transplantation. Curr. Opin. Urol. 12(6), 479–484 (2002)

    Article  PubMed  Google Scholar 

  17. T. Tarcan, S. Bauer, E. Olmedo, S. Khoshbin, M. Kelly, M. Darbey, Long-term followup of newborns with myelodysplasia and normal urodynamic findings: Is followup necessary? J. Urol. 165(2), 564–567 (2001)

    Article  CAS  PubMed  Google Scholar 

  18. L.S. Palmer, I. Richards, W.E. Kaplan, Subclinical changes in bladder function in children presenting with nonurological symptoms of the tethered cord syndrome. J. Urol. 159(1), 231–234 (1998)

    Article  CAS  PubMed  Google Scholar 

  19. J.H. Tseng, M.F. Kuo, T.Y. Kwang, M.Y. Tseng, Outcome of untethering for symptomatic spina bifida occulta with lumbosacral spinal cord tethering in 31 patients: Analysis of preoperative prognostic factors. Spine J. 8(4), 630–638 (2008)

    Article  PubMed  Google Scholar 

  20. R. DasGupta, C.J. Fowler, Sexual and urological dysfunction in multiple sclerosis: Better understanding and improved therapies. Curr. Opin. Neurol. 15, 271–278 (2002)

    Article  PubMed  Google Scholar 

  21. T. Wang, W. Huang, Y. Zhang, Clinical characteristics and urodynamic analysis of urinary dysfunction in multiple sclerosis. Chin. Med. J. 129(6), 645–650 (2016)

    Article  PubMed  PubMed Central  Google Scholar 

  22. J. Krhut, P. Hradílek, O. Zapletalová, Analysis of the upper urinary tract function in multiple sclerosis patients. Acta Neurol. Scand. 118(2), 115–119 (2008)

    Article  CAS  PubMed  Google Scholar 

  23. N.A. Shakir, A. Satyanarayan, J. Eastman, et al., Assessment of renal deterioration and associated risk factors in patients with multiple sclerosis. Urology 123, 76–80 (2019 Jan)

    Article  PubMed  Google Scholar 

  24. A. Wiedemann, M. Kaeder, W. Greulich, H. Lax, J. Priebel, R. Kirschner-Hermanns, et al., Which clinical risk factors determine a pathological urodynamic evaluation in patients with multiple sclerosis? An analysis of 100 prospective cases. World J. Urol. 31(1), 229–233 (2013)

    Article  CAS  PubMed  Google Scholar 

  25. G.A. Barbalias, G. Nikiforidis, E.N. Liatsikos, Vesicourethral dysfunction associated with multiple sclerosis: Clinical and urodynamic perspectives. J. Urol. 160(1), 106–111 (1998)

    Article  CAS  PubMed  Google Scholar 

  26. J.G. Blaivas, Management of bladder dysfunction in multiple sclerosis. Neurology 30, 12–18 (1980)

    Article  CAS  PubMed  Google Scholar 

  27. G.E. Lemack, E. Frohman, P. Ramnarayan, Women with voiding dysfunction secondary to bladder outlet dyssynergia in the setting of multiple sclerosis do not demonstrate significantly elevated intravesical pressures. Urology 69(5), 893–897 (2007)

    Article  PubMed  Google Scholar 

  28. V. Phé, M. Pakzad, C. Curtis, B. Porter, C. Haslam, J. Chataway, et al., Urinary tract infections in multiple sclerosis. Mult. Scler. 22(7), 855–861 (2016)

    Article  PubMed  Google Scholar 

  29. J. Krhut, P. Hradilek, D. Nemec, J. Tvrdik, O. Zapletalova, P. Zvara, Incidence of the urological tumours in patients suffering from multiple sclerosis. Acta Neurol. Scand. 130(3), 193–196 (2014)

    Article  CAS  PubMed  Google Scholar 

  30. C. Confavreux, P. Saddier, J. Grimaud, T. Moreau, P. Adeleine, G. Aimard, Risk of cancer from azathioprine therapy in multiple sclerosis: A case-control study. Neurology 46(6), 1607–1612 (1996)

    Article  CAS  PubMed  Google Scholar 

  31. A.V. Badri, R.S. Purohit, J. Skenazy, J.P. Weiss, J.G. Blaivas, A review of lower urinary tract symptoms in patients with Parkinson’s disease. Curr. Urol. Rep. 15(9), 435–413 (2014)

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter Zvara .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Singapore Pte Ltd.

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Zvara, P. (2023). Follow-Up. In: Liao, L., Madersbacher, H. (eds) Handbook of Neurourology. Springer, Singapore. https://doi.org/10.1007/978-981-99-1659-7_58

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-1659-7_58

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-1658-0

  • Online ISBN: 978-981-99-1659-7

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics